SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (140)2/2/1998 11:28:00 AM
From: Mark Adams  Read Replies (1) of 186
 
Not knowing the exact bacteria, instead patting the patient on the back as they leave with their antibiotic prescription only to return for another if the problem doesn't clear up has led us to this point.

Lab costs to identify the exact problem take time and cost money. I would say we've counted on antibiotics as the silver bullet for too long.

BTW, in watching CNN last night, re vacciniations in the third world, it occurred to me that there is a real disconnect between 'excess capacity in SE Asia' and the dirth of vaccine supply in the third world. Clearly capitalism has a flaw or two if not tempered by intelligent spending by a central authority.

MCDE down over $1 on double normal volume- ouch.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News